“…PBL are the least immunosuppressed population of effector cells. Early in the disease process, PBL respond normally to mitogens such as phytohemagglutinin (PHA), concanavalin A (Con A), or other stimuli, whereas with progression of cancer, these responses deteriorate 72,78–87 . Patients with early stage HNSCC have normal T‐cell counts and CD4:CD8 ratios in their peripheral blood, whereas patients with advanced disease have reduced counts, decreased numbers of CD4+ cells, and small reductions in CD8+ cells 77,78,88–94 …”